LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the ROTH Capital Partners 20th Annual OC Growth Stock Conference on Tuesday, February 19, 2008 at 10:00 am (ET) at the Ritz-Carlton Laguna Niguel, California.
